Advertisement
Advertisement

EMBC

EMBC logo

Embecta Corp. Common Stock

8.87
USD
Sponsored
-0.13
-1.42%
Mar 26, 15:59 UTC -4
Closed
exchange

After-Market

8.88

+0.01
+0.09%

EMBC Earnings Reports

Positive Surprise Ratio

EMBC beat 12 of 15 last estimates.

80%

Next Report

Date of Next Report
May 07, 2026
Estimate for Q2 26 (Revenue/ EPS)
$240.28M
/
$0.42
Implied change from Q1 26 (Revenue/ EPS)
-8.01%
/
-40.85%
Implied change from Q2 25 (Revenue/ EPS)
-7.23%
/
-40.00%

Embecta Corp. Common Stock earnings per share and revenue

On Feb 05, 2026, EMBC reported earnings of 0.71 USD per share (EPS) for Q1 26, beating the estimate of 0.68 USD, resulting in a 3.89% surprise. Revenue reached 261.20 million, compared to an expected 263.20 million, with a -0.76% difference. The market reacted with a -7.75% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of 0.42 USD, with revenue projected to reach 240.28 million USD, implying an decrease of -40.85% EPS, and decrease of -8.01% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
logo
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
logo
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
logo
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
logo
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
logo
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
logo
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
logo
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
For Q1 2026, Embecta Corp. Common Stock reported EPS of $0.71, beating estimates by 3.89%, and revenue of $261.20M, -0.76% below expectations.
The stock price moved down -7.75%, changed from $11.35 before the earnings release to $10.47 the day after.
The next earning report is scheduled for May 07, 2026.
Based on 5 analysts, Embecta Corp. Common Stock is expected to report EPS of $0.42 and revenue of $240.28M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement